Your browser doesn't support javascript.
loading
Cervical cancer screening outcomes for HIV-positive women in the Lubombo and Manzini regions of Eswatini-Prevalence and predictors of a positive visual inspection with acetic acid (VIA) screen.
Mapaona, Rufaro; Williams, Victor; Musarapasi, Normusa; Kibwana, Sharon; Maseko, Thokozani; Chekenyere, Rhinos; Gumbo, Sidumo; Mdluli, Phetsile; Byarugaba, Hugben; Galagedera, Dileepa; Mafukidze, Arnold; Hurtado-de-Mendoza, Alejandra; Adsul, Prajakta; Bongomin, Pido; Loffredo, Christopher; Dlamini, Xolisile; Bazira, Deus; Ojoo, Sylvia; Haumba, Samson.
Afiliación
  • Mapaona R; Center for Global Health Practice and Impact, Georgetown University, Mbabane, Eswatini.
  • Williams V; Center for Global Health Practice and Impact, Georgetown University, Mbabane, Eswatini.
  • Musarapasi N; Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Kibwana S; Center for Global Health Practice and Impact, Georgetown University, Mbabane, Eswatini.
  • Maseko T; Center for Global Health Practice and Impact, Georgetown University Medical Center, Washington, DC, United States of America.
  • Chekenyere R; Center for Global Health Practice and Impact, Georgetown University, Mbabane, Eswatini.
  • Gumbo S; Center for Global Health Practice and Impact, Georgetown University, Mbabane, Eswatini.
  • Mdluli P; Center for Global Health Practice and Impact, Georgetown University, Mbabane, Eswatini.
  • Byarugaba H; Center for Global Health Practice and Impact, Georgetown University, Mbabane, Eswatini.
  • Galagedera D; Center for Global Health Practice and Impact, Georgetown University, Mbabane, Eswatini.
  • Mafukidze A; Center for Global Health Practice and Impact, Georgetown University, Mbabane, Eswatini.
  • Hurtado-de-Mendoza A; Center for Global Health Practice and Impact, Georgetown University, Mbabane, Eswatini.
  • Adsul P; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States of America.
  • Bongomin P; University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States of America.
  • Loffredo C; Center for Global Health Practice and Impact, Georgetown University, Mbabane, Eswatini.
  • Dlamini X; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States of America.
  • Bazira D; National Cancer Control Program, Ministry of Health, Mbabane, Eswatini.
  • Ojoo S; Center for Global Health Practice and Impact, Georgetown University Medical Center, Washington, DC, United States of America.
  • Haumba S; Center for Global Health Practice and Impact, Georgetown University Medical Center, Washington, DC, United States of America.
PLOS Glob Public Health ; 4(4): e0002760, 2024.
Article en En | MEDLINE | ID: mdl-38625931
ABSTRACT
This study aimed to describe the prevalence and predictors of a positive VIA (visual inspection with acetic acid) cervical cancer screening test in women living with human immunodeficiency virus (HIV). We retrospectively analysed data from women aged ≥15 who accessed VIA screening from health facilities in the Lubombo and Manzini regions of Eswatini. Sociodemographic and clinical data from October 2020 to June 2023 were extracted from the client management information system (CMIS). VIA screening outcome was categorised into negative, positive, or suspicious. A logistic regression model estimated the adjusted odds ratio (AOR) of the predictors of a positive VIA screen at p<0.05 with 95% confidence intervals. Of 23,657 participants, 60.8% (n = 14,397) were from the Manzini region. The mean age was 33.3 years (standard deviation 7.0), and 33% (n = 7,714) were first-time screens. The prevalence of a positive VIA was 2.6% (95% CI 2.2%, 3.0%) 2.8% (95% CI 2.2%, 3.5%) in Lubombo and 2.4% (95% CI 2.0%, 2.9%) in Manzini (p = 0.096). Screening at mission-owned (AOR 1.40; p = 0.001), NGO-owned (AOR 3.08; p<0.001) and industrial/workplace-owned health facilities (AOR 2.37; p = 0.044) were associated with increased odds of a positive VIA compared to government-owned health facilities. Compared to those aged 25-34, the odds of a positive VIA increased by 1.26 for those in the 35-44 age group (AOR 1.26; p = 0.017). Predictors with lower odds for a positive VIA test were being on anti-retroviral therapy (ART) for 5-9 years (AOR 0.76; p = 0.004) and ≥10 years (AOR 0.66; p = 0.002) compared to <5 years; and having an undetectable viral load (AOR 0.39; p<0.001) compared to unsuppressed. Longer duration on ART and an undetectable viral load reduced the odds, while middle-aged women and screening at non-public health facilities increased the odds of a positive VIA screen.

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: PLOS Glob Public Health Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: PLOS Glob Public Health Año: 2024 Tipo del documento: Article